Answers are grounded in this paper and cite their sources.
Relative to the standard formula, the diabetes-specific formula reduced postprandial glycemia, mean glucose, glycemic variability, and short-acting insulin requirements. These results suggest potential clinical usefulness of a diabetes-specific enteral formula for minimizing glycemic excursions in hospitalized patients.
No takes yet. Share an insight, caveat, or question.
Alish et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: